戻る Agenda
GVP Module XVI - Risk minimisation measures: Selection of tools and effectiveness indicators (REV 3)- cont.
Speaker(s)
METHODS FOR EFFECTIVENESS EVALUATION OF RISK MINIMISATION MEASURES (RMMs)
Thomas Goedecke, PHARMD, PHD
European Medicines Agency, Netherlands
Senior Pharmacovigilance Specialist
MONITORING THE EFFECTIVENESS OF RMMs: FROM THEORY TO PRACTISE
Daniel Morales, MD, PHD, MRCP
European Medicines Agency, Netherlands
Epidemiologist
Q&A AND PANEL DISCUSSION INCLUDING:
Priya Bahri, PHD, RPH
European Medicines Agency, Netherlands
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy)
Q&A AND PANEL DISCUSSION INCLUDING:
Viola Macolic Sarinic, DRSC, MD, MSC
European Medicines Agency, Netherlands
Scientific Officer